نتایج جستجو برای: brca1

تعداد نتایج: 8182  

2015
Tesa M. Severson Justine Peeters Ian Majewski Magali Michaut Astrid Bosma Philip C. Schouten Suet-Feung Chin Bernard Pereira Mae A. Goldgraben Tycho Bismeijer Roelof J.C. Kluin Jettie J.F. Muris Karin Jirström Ron M. Kerkhoven Lodewyk Wessels Carlos Caldas René Bernards Iris M. Simon Sabine Linn

Triple negative (TN) breast cancers make up some 15% of all breast cancers. Approximately 10-15% are mutant for the tumor suppressor, BRCA1. BRCA1 is required for homologous recombination-mediated DNA repair and deficiency results in genomic instability. BRCA1-mutated tumors have a specific pattern of genomic copy number aberrations that can be used to classify tumors as BRCA1-like or non-BRCA1...

2013
Fang-Fang Bi Da Li Chen Cao Chun-Yan Li Qing Yang

BACKGROUND Both BRCA1 and angiotensin II type 1 receptor (AGTR1) play a critical role in ovarian cancer progression. However, the crosstalk between BRCA1 and AGTR1 signaling pathways remains largely unknown. METHODS BRCA1 promoter methylation was analyzed by bisulfite sequence using primers focused on the core promoter region. Expression levels of BRCA1 and AGTR1 were assessed by immunohistoc...

2014
Maud Privat Nina Radosevic-Robin Corinne Aubel Anne Cayre Frédérique Penault-Llorca Geoffroy Marceau Vincent Sapin Yves-Jean Bignon Daniel Morvan

The hypermetabolic nature of cancer cells and their increased reliance on "aerobic glycolysis", as originally described by Otto Warburg and colleagues, are considered metabolic hallmarks of cancer cells. BRCA1 is a major tumor suppressor in breast cancer and it was implicated in numerous pathways resulting in anticarcinogenic functions. The objective of our study was to address specific contrib...

2013
Da Li Fang-Fang Bi Ji-Min Cao Chen Cao Chun-Yan Li Qing Yang

BACKGROUND Both BRCA1 and epidermal growth factor receptor (EGFR) play a critical role in ovarian cancer progression. However, the crosstalk between BRCA1 and EGFR signaling pathways in ovarian cancer remains largely unknown. METHODS The effect of BRCA1 on EGFR was assessed in 146 serous ovarian cancer patients (28 pairs of BRCA1-mutated or not, 23 pairs of BRCA2-mutated or not, and 22 pairs ...

Journal: :Cancer research 2011
Juhong Jiang Eddy S Yang Guochun Jiang Somaira Nowsheen Hong Wang Tong Wang Yihan Wang Dean Billheimer A Bapsi Chakravarthy Melissa Brown Bruce Haffty Fen Xia

Subcellular localization regulates BRCA1 function, and BRCA1 is exported to the cytoplasm following DNA damage in a p53-dependent manner. Because more than 50% of solid tumors harbor p53 mutations, it is possible that genetically wild-type (wt) BRCA1 is functionally abnormal through compromised nuclear-cytoplasmic shuttling in sporadic breast cancer patients with dysfunctional p53. In this stud...

ژورنال: :genetics in the 3rd millennium 0
رکسانا مصلحی roxana moslehi وهرز غفاری vahraz ghaffari حسین نجم آبادی hossein najmabadi محمد حسن کریمی نژاد mohammad hassan kariminejad

اخیرا تعیین ژن های جهشی سندرم سرطان پستان و تخمدان در اقوام مختلفی گزارش و بر اهمین آن در پیشگیری از بروز بدخیمی تاکید شده است. به منظور بررسی ژن های جهشی این سندرم در جمعیت ایران و پیشگیری از بروز سرطان، از چند خانواده ایرانی که در بین آن ها سرطان های متعدد از قبیل مواردی از سرطان پستان و تخودان وجود داشت. پس از انجام مشاوره ژنتیک و تنظیم شجره نامه از مبتلایان و بستگان درجه اول آنها، نمونه گیر...

Journal: :Journal of the National Cancer Institute 2002
John P Geisler Melanie A Hatterman-Zogg Jennifer A Rathe Richard E Buller

BACKGROUND Ovarian cancer is one of the most common hereditary cancers in women. Mutations in the BRCA1 gene increase a woman's risk of ovarian cancer. Testing for BRCA1 mutations is cumbersome and impractical for large populations. Therefore, we developed an efficient strategy to detect various types of BRCA1 dysfunction and also determined the relative frequency of BRCA1 dysfunction in ovaria...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
O N Aprelikova B S Fang E G Meissner S Cotter M Campbell A Kuthiala M Bessho R A Jensen E T Liu

BRCA1 is a susceptibility gene for breast and ovarian cancer with growth-inhibitory activity for which the mechanism of action remains unclear. When introduced into cells, BRCA1 inhibits growth of some but not all cell lines. In an attempt to uncover the mechanism of growth suppression by BRCA1, we examined a panel of cell lines for their ability to reduce colony outgrowth in response to BRCA1 ...

2014
Priyanka Sharma Shane R. Stecklein Bruce F. Kimler Geetika Sethi Brian K. Petroff Teresa A. Phillips Ossama W. Tawfik Andrew K. Godwin Roy A. Jensen

INTRODUCTION Methylation of the BRCA1 promoter is frequent in triple negative breast cancers (TNBC) and results in a tumor phenotype similar to BRCA1-mutated tumors. BRCA1 mutation-associated cancers are more sensitive to DNA damaging agents as compared to conventional chemotherapy agents. It is not known if there is an interaction between the presence of BRCA1 promoter methylation (PM) and res...

2016
Laudine Communal Myriam Vilasco Justine Hugon-Rodin Aurélie Courtin Najat Mourra Najiba Lahlou Morwenna Le Guillou Muriel Perrault de Jotemps Marie-Pierre Chauvet Marc Chaouat Pascal Pujol Jean Feunteun Suzette Delaloge Patricia Forgez Anne Gompel

Women with inherited BRCA1 mutations have an elevated risk (40-80%) for developing breast and ovarian cancers. Reproductive history has been reported to alter this risk, suggesting a relationship between ovarian hormone signaling and BRCA1-related tumor development. BRCA1 interactions with estrogen receptor (ER) and progesterone receptor (PR) signaling were previously described in human breast ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید